In a collaborative study, Dr. John R. Lee and colleagues revealed a first-of-its-kind discovery showing that the abundance of uropathogens in the gut is associated with future development of UTI.
Dr. Suthanthiran's talk was entitled “Monitoring the Allograft in the 21st Century: From the Microscope to Molecular Scan.”
The paper illuminates a technique that has enabled a low-cost urine test that can identify thousands of bacteria and viruses in humans. Importantly, infections causing tissue damage can be readily discerned.
The newsletter’s feature was in recognition of Dr. Lee’s pivotal abstract that presented an evaluation of the gut microbiota in 169 kidney transplant recipients.
The study, which utilized urine samples and cell-free DNA sequencing, yielded critical information on both the dynamics of infections and the patients’ particular biological responses.
This award was founded to encourage outstanding research in women’s health. The finalists presented their work at Medicine Grand Rounds.
In this newly funded project, Drs. Choi will examine the mechanisms by which RIPK3 regulates kidney and lung fibrosis, as well as seek to uncover new biomarkers and molecular targets that can be utilized for diagnosis and treatment.
Dr. Lee’s study holds great promise for patients on peritoneal dialysis who are vulnerable to acquiring peritonitis, an infection that can cause significant morbidity and even death.
The Weill Department of Medicine is focused on increasing its research footprint both at Weill Cornell and on a national level. To that end, the department has established a mentoring infrastructure to assist junior faculty during their transition to NIH K and R series grants. This infrastructure supports a monthly meeting that seeks to build, promote, and mentor the department's junior faculty.
The Suthanthiran Laboratory's innovative discovery to determine acute rejection in the kidney transplant (by measuring three genes in the urine), and ultimately reducing the need of a kidney transplant biopsy, was selected as one of Top 10 Outstanding Clinical Research Achievements in the U.S. by the Clinical Research Forum.